IL-17 induces myocardial fibrosis and enhances RANKL/OPG and MMP/TIMP signaling in isoproterenol-induced heart failure

被引:148
作者
Feng, Weiwei [1 ]
Li, Weimin [1 ]
Liu, Wei [1 ]
Wang, Fang [1 ]
Li, Yue [1 ]
Yan, Wei [1 ]
机构
[1] Harbin Med Univ, Affiliated Hosp 1, Dept Cardiol, Harbin 150001, Heilongjiang, Peoples R China
关键词
Interleukin-17; Isoproterenol-induced heart failure; Myocardial fibrosis; Matrix metalloproteinase; Tissue inhibitor of metalloproteinase; Osteoprotegerin; Receptor activator of nuclear factor-kappa B ligand; Collagens; NF-KAPPA-B; MATRIX METALLOPROTEINASE-3 SECRETION; RECEPTOR ACTIVATOR; INHIBITION; EXPRESSION; LIGAND; INTERLEUKIN-17; MYOFIBROBLASTS; DELETION; AXIS;
D O I
10.1016/j.yexmp.2009.06.001
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objective: This study was designed to investigate whether IL-17 can regulate the expression of the MMP/TIMP system, the OPG/RANK/RANKL system, or type-I and type-III collagen fibers in a rat model of isoproterenol-induced heart failure (HF). We also investigated the effect of IL-17 on myocardial fibrosis in this model. Methods: HF was induced in Wistar-Kyoto rats by hypodermic injection of isoproterenol (ISO) twice every 24 h. After 2 months, the surviving rats were divided into three groups: monoclonal Anti-IL-17 Ab (100 mu g/day), IgG (100 mu g/day) or PBS were injected five times every 48 h (i.p.). One day after the last injection, all of the rats were sacrificed. H&E and Masson staining were used to evaluate myocardial fibrosis, and immunohistochemistry was used to measure the levels of MMP-1, TIMP-1, TIMP-4, OPG, RANKL, type-I and type-III collagen fibers. We also treated adult rat cardiac fibroblasts with IL-17 (10 ng/ml), IL-17 (10 ng/ml) + OPG (10 ng/ml), IL-17 (10 ng/ml) + anti-RANKL Ab (100 ng/ml), or PBS for 24 h, realtime RT-PCR was used to measure the expressions of MMP-1. Results: The expressions of MMP-1, RANKL, and type-I and -III collagen fibers decreased, and the expressions of TIMP-1, TIMP-4, and OPG increased in the Anti-IL-17 group compared to controls. H&E and Masson staining revealed that blockade of IL-17 can improve myocardial fibrosis in HE IL-17 increased the expression of MMP-1 in cardiac fibroblasts, and OPG and anti-IL-17 Ab could inhibit this function partly. Thus, IL-17 was dependent on the RANKL/OPG system to induce MMP-1 partly. Conclusion: Our study demonstrates the contribution of IL-17 to myocardial fibrosis in isoproterenol-induced HE IL-17 can regulate the RANKL/OPG and MMP/TIMP systems in this model. The RANKL/OPG system is one of intermediaries between IL-17 and MMP-1 in cardiac fibroblasts. As a harmful cytokine, anti-IL-17 treatment is a potential therapeutic strategy in HF. (C) 2009 Published by Elsevier Inc.
引用
收藏
页码:212 / 218
页数:7
相关论文
共 29 条
[1]  
Aggarwal S, 2002, J LEUKOCYTE BIOL, V71, P1
[2]   A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function [J].
Anderson, DM ;
Maraskovsky, E ;
Billingsley, WL ;
Dougall, WC ;
Tometsko, ME ;
Roux, ER ;
Teepe, MC ;
DuBose, RF ;
Cosman, D ;
Galibert, L .
NATURE, 1997, 390 (6656) :175-179
[3]   Matrix metalloproteinase-3 secretion from human colonic subepithelial myofibroblasts: role of interleukin-17 [J].
Bamba, S ;
Andoh, A ;
Yasui, H ;
Araki, Y ;
Bamba, T ;
Fujiyama, Y .
JOURNAL OF GASTROENTEROLOGY, 2003, 38 (06) :548-554
[4]   MMPs, IL-1, and TNF are regulated by IL-17 in periodontitis [J].
Beklen, A. ;
Ainola, M. ;
Hukkanen, M. ;
Gurgan, C. ;
Sorsa, T. ;
Konttinen, Y. T. .
JOURNAL OF DENTAL RESEARCH, 2007, 86 (04) :347-351
[5]   IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-β, NF-κB, and AP-1 activation [J].
Cortez, Dolores M. ;
Feldman, Marc D. ;
Mummidi, Srinivas ;
Valente, Anthony J. ;
Steffensen, Bjorn ;
Vincenti, Matthew ;
Barnes, Jeffrey L. ;
Chandrasekar, Bysani .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2007, 293 (06) :H3356-H3365
[6]  
Esler M, 2000, Heart Fail Rev, V5, P17
[7]   Chronic blocking of β3-adrenoceptor ameliorates cardiac function in rat model of heart failure [J].
Gan Run-tao ;
Li Wei-min ;
Xiu Chun-hong ;
Shen Jing-xia ;
Wang Xu ;
Wu Shuang ;
Kong Yi-hui .
CHINESE MEDICAL JOURNAL, 2007, 120 (24) :2250-2255
[8]   Role of interleukin-17 and interieukin-17-induced cytokines interleukin-6 and interleukin-8 in unstable coronary artery disease [J].
Hashmi, Satwat ;
Zeng, Qiu Tang .
CORONARY ARTERY DISEASE, 2006, 17 (08) :699-706
[9]   Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure [J].
Heymans, S ;
Luttun, A ;
Nuyens, D ;
Theilmeier, G ;
Creemers, E ;
Moons, L ;
Dyspersin, GD ;
Cleutjens, JPM ;
Shipley, M ;
Angellilo, A ;
Levi, M ;
Nübe, O ;
Baker, A ;
Keshet, E ;
Lupu, F ;
Herbert, JM ;
Smits, JFM ;
Shapiro, SD ;
Baes, M ;
Borgers, M ;
Collen, D ;
Daemen, MJAP ;
Carmeliet, P .
NATURE MEDICINE, 1999, 5 (10) :1135-1142
[10]   The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption [J].
Hofbauer, LC ;
Khosla, S ;
Dunstan, CR ;
Lacey, DL ;
Boyle, WJ ;
Riggs, BL .
JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (01) :2-12